Functional B cell abnormalities in HIV type 1 infection: Role of CD40L and CD70

AIDS Research and Human Retroviruses

Volumn 13, Issue 12, 1997, Pages 1023-1029

  Wolthers, Katja C ^a,c   Otto, Sigrid A ^a   Lens, Susanne M A ^a   Van Lier, René A W ^a   Miedema, Frank ^a   Meyaard, Linde ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MERCK RESEARCH LABORATORIES   (United States)

^c CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10;

ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGLOBULIN PRODUCTION; MALE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; T LYMPHOCYTE;

EID: 0030872772     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.1023     Document Type: Article

References (45)

1. + T helper cell depletion occurs. J Clin Invest 1988;82: 1908-1914.
2. Terpstra FG, Al BJM, Roos MThL, et al.: Longitudinal study of leukocyte functions in homosexual men seroconverted for HIV-1: Rapid and persistent loss of B-cell function after HIV-1 infection. Eur J Immunol 1989;19:667-673.
3. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, and Fauci AS: Abnormalities of B-cell activation and immunoregulation in patients with acquired immunodeficiency syndrome. N Engl J Med 1983;309:453-458.
4. Pahwa S, Pahwa R, Saxinger C, Gallo RC, and Good RA: Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: Evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations. Proc Natl Acad Sci USA 1985;82:198-202.
5. Pahwa S, Pahwa R, Good RA, et al.: Stimulatory and inhibitory influences of human immunodeficiency virus on normal B lymphocytes. Proc Natl Acad Sci USA 1986;83:9124-9128.
6. Yarchoan R, Redfield R, and Broder S: Mechanism of B-cell activation in patients with the acquired immunodeficiency syndrome and related disorders. J Clin Invest 1986;78:439-447.
7. Teeuwsen VJP, Logtenberg T, Siebelink KHJ, et al.: Analysis of the antigen- and mitogen-induced differentiation of B lymphocytes from asymptomatic human immunodeficiency virus-seropositive male homosexuals. J Immunol 1987;139:2929-2935.
8. Amadori A and Chieco-Bianchi L: B-cell activation and HIV-1 infection: Deeds and misdeeds. Immunol Today 1990;11:374-379.
9. Kroon FP, Van Dissel JT, De Jong JC, and Van Furth R: Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS 1994;8:469-476.
10. Ballet JJ, Couderc LJ, Rabian-Herzog C, et al.: Impaired T-lymphocyte-dependent immune responses to microbial antigens in patients with HIV-1-associated persistent generalized lymphadenopathy. AIDS 1988;2:291-297.
11. Steinhoff MC, Auerbach BS, Nelson KE, et al.: Antibody responses to Haemophilia influence type B vaccines in men with human immunodeficiency virus infection. N Engl J Med 1991;325: 1837-1842.
12. Huang KL, Ruben FL, Rinaldo CR, Kingsley L, Lyter DW, and Ho M: Antibody responses after influenza and pneumococcal immunization in HIV-infected men. JAMA 1987;257:2047-2050.
13. Ballet JJ, Sulcebe G, Couderc LJ, et al.: Impaired anti-pneumococcal antibody response in patients with AIDS-related persistent generalized lymphadenopathy. Clin Exp Immunol 1987; 68:1-9.
14. Ammann AJ, Schiffman G, Abrams D, Volberding P, Ziegler J, and Conant M: B-cell immunodeficiency in acquired immunodeficiency syndrome. JAMA 1984;251:1447-1449.
15. Nakajima K, Martínez-Maza O, Hirano T, et al.: Induction of IL-6 (B cell stimulatory factor-2/IFN-β2) production by HIV. J Immunol 1989;142:531-536.
16. Breen EC, Rezai AR, Nakajima K, et al.: Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990;144:480-484.
17. Clark EA and Ledbetter JA: How B and T cells talk to each other. Nature (London) 1994;367:425-428.
18. Armitage RJ and Alderson MA: B-cell stimulation. Curr Opin Immunol 1995;7:243-247.
19. Noelle RJ, Ledbetter JA, and Aruffo A: CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol Today 1992;13:431-433.
20. Banchereau J, Bazan J, Blanchard D, et al.: The CD40 antigen and its ligand. Annu Rev Immunol 1994;12:881-922.
21. Armitage RJ, Sato TA, Macduff BM, et al.: Identification of a source of biologically active CD40 ligand. Eur J Immunol 1992; 22:2071-2076.
22. Noelle RJ, Roy M, Shepherd DM, Stamenkovic I, Ledbetter JA, and Aruffo A: A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci USA 1992;89:6550-6554.
23. Lane P, Traunecker A, Hubele S, Inui S, Lanzavecchia A, and Gray D: Activated human T cells express a ligand for the human B-cell associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur J Immunol 1992;22:2573-2578.
24. Hollenbaugh D, Grosmaire LS, Kullas CD, et al.: The human antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: Expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 1992;11:4313-4321.
25. Spriggs MK, Armitage RJ, Strockbine L, et al.: Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J Exp Med 1992;176:1543-1550.
26. Van Lier RAW, Oudkerk Pool M, Kabel P, et al.: Anti-CD27 monoclonal antibodies identify two functionally distinct subpopulations within the CD4+ T cell subset. Eur J Immunol 1988; 18:811-816.
27. Maurer D, Fischer GF, Fae I, et al.: IgM and IgG but not cytokine secretion is restricted to the CD27+ B lymphocyte subset. J Immunol 1992;146:2488.
28. Van Lier RAW, Borst J, Vroom TM, et al.: Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J Immunol 1987;139:1589-1596.
29. Maurer D, Holter W, Majdic O, Fischer GF, and Knapp W: CD27 expression by a distinct subpopulation of human B lymphocytes. Eur J Immunol 1990;20:2679.
30. Goodwin RG, Alderson MR, Smith CA, et al.: Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 1993; 73:447-456.
31. Hintzen RQ, Lens SMA, Koopman G, Pals ST, Spits H, and Van Lier RAW: CD70 represents the human ligand for CD27. Int Immunol 1993;6:477-480.
32. Lens SMA, De Jong R, Hooibrink B, et al.: Phenotype and function of human B cells expressing CD70 (CD27 ligand). Eur J Immunol 1996;26:2964-2971.
33. Agematsu K, Kobata T, Sugita K, et al.: Role of CD27 in T cell immune response. J Immunol 1994;153:1421.
34. Agematsu K, Kobata T, Yang FC, et al.: CD27/CD70 interaction directly drives B cell IgG and IgM synthesis. Eur J Immunol 1995; 25:2825-2829.
35. De Wolf F, Lange JMA, Houweling JTM, et al.: Numbers of CD4+ cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men. J Infect Dis 1988;158:615-622.
36. Van Kemenade FJ, Tellegen E, Maurice MM, et al.: Simultaneous regulation of CD2 adhesion and signalling functions by a novel CD2 monoclonal antibody. J Immunol 1994;152:4425-4432.
37. Clark EA and Ledbetter JA: Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc Natl Acad Sci USA 1986;83:4494.
38. Rousset F, Garcia E, Defrance T, et al.: Interleukin 10 is a potent growth and differentiation factor for activated human B cells. Proc Natl Acad Sci USA 1992;89:1890.
39. Lankester AC, Rood PML, Van Schijndel GMW, Hooibrink B, Verhoeven AJ, and Van Lier RAW: Alteration of B-cell antigen receptor signaling by CD19 co-ligation. A study with bispecific antibodies. J Biol Chem 1996;271(37): 22326-22330.
40. Lederman S, Yellin MJ, Krichevsky A, Belko J, Lee JJ, and Chess L: Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help). J Exp Med 1992;175:1091-1101.
41. Kuritani T and Cooper MD: Human B-cell differentiation. II. Poke-weed mitogen-responsive B cells belong to a surface immunoglobulin-D-negative subpopulation. J Exp Med 1982;155:1561.
42. Brugnoni D, Prati E, Airo P, Castelli F, and Cattaneo R: The ability of CD4+ T cells from HIV+ individuals to express CD40 ligand after in vitro stimulation is not impaired. Clin Immunol Immunopathol 1995;74:112-114.
43. Janossy G, Pinching AJ, Bofill M, et al.: An immunohistological approach to persistent lymphadenopathy and its relevance to AIDS. Clin Exp Immunol 1985;59:257-266.
44. Wood GS, Garcia CF, Dorfman RF, and Warnke RA: The immunohistology of follicle lysis in lymph node biopsies from homosexual men. Blood 1985;66:1092-1097.
45. Macchia D, Almerigogna F, Parronchi P, Ravina A, Maggi E, and Romagnani S: Membrane tumour necrosis factor-α is involved in the polyclonal B-cell activation induced by HIV-infected human T cells. Nature (London) 1993;363:464-466.